Position in NRIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,181,267
+$400,734 QoQ
Shares Held
48,692
-3.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#102
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. NRIX ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,181,267 | 48,692 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $780,533 | 50,357 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $897,053 | 47,288 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $439,203 | 47,533 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $574,988 | 50,482 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $542,795 | 45,690 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $582,061 | 30,895 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,531,284 | 68,148 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $767,931 | 36,796 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $504,561 | 34,324 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $495,255 | 47,990 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $415,722 | 52,891 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $527,740 | 52,827 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $317,326 | 35,735 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $978,272 | 89,096 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $368,409 | 28,274 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,641,080 | 129,525 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,688,427 | 120,516 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,601,214 | 89,852 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,737,229 | 57,985 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $765,044 | 28,837 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $369,938 | 11,899 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $171,995 | 5,231 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $144,527 | 4,140 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||